Method for the preparation of hexahydro-furo[2,3-b)furan-3-ol

Details for Australian Patent Application No. 2002333809 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Kesteleyn, Bart Rudolf Romanie; Surleraux, Dominique Louis Nestor Ghislain

Agent Shelston IP

Pub. Number AU-B-2002333809

PCT Number PCT/EP02/10062

PCT Pub. Number WO2003/022853

Priority 01203416.1 10.09.01 EP

Filing date 6 September 2002

Wipo publication date 24 March 2003

Acceptance publication date 28 February 2008

International Classifications

C07D 307/16 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 205/15 (2006.01) Compounds containing nitro groups bound to a carbon skeleton

C07C 205/29 (2006.01) Compounds containing nitro groups bound to a carbon skeleton

C07D 307/20 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 493/04 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 01203416.1 10.09.01 EP

19 June 2003 Application Open to Public Inspection

  Published as AU-B-2002333809

28 February 2008 Application Accepted

  Published as AU-B-2002333809

26 June 2008 Standard Patent Sealed

3 July 2008 Corrigenda

  Applications Accepted - Name Index Under the Name Tibotec Pharmaceuticals Ltd., Application No. 2002333809, under INID (72) and (54), correct the name of the inventor to include Quaedflieg, Peter Jan Leonard Mario and correct the title to Method for the preparation of hexahydrofuro[2,3-b]furan-3-ol Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2002234474 FRAMA AG 20

2 October 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 12 Jun 2008. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000

5 February 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 12 Jun 2008 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002333810-REGULATION OF HUMAN TAUTUBULIN KINASE

2002333808-DIAGNOSTIC AND THERAPEUTIC USE OF F-BOX PROTEINS FOR ALZHEIMER'S DISEASE AND RELATED NEURODEGENERATIVE DISORDERS